IL6ST and neoplasm: IL6ST expression strongly correlates with earlier disease stages. In advanced stages, IL6ST expression is associated with better prognosis and higher OS and DFS rates.IL6ST negatively correlates with lymph node status and tumour size.IL6ST is independent from other well established clinicopathological factors.